The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Syneos Health, Inc. (Syneos or the Company) (NASDAQ: SYNH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Syneos disclosed during aftermarket on February 27, 2019, that on February 21, 2019, the Securities and Exchange Commission (SEC) notified the Company that it has commenced an investigation into the Companys revenue accounting policies, internal controls and related matters, and requested that the Company retain certain documents for the periods beginning with January 1, 2017. As an additional measure prior to the Company filing the Form 10-K, the Audit Committee of the Companys Board of Directors is conducting an independent review of the Companys revenue accounting policies, internal controls and related matters with the assistance of outside counsel and accounting advisors. Based on this news, shares of Syneos fell sharply during aftermarket trading on the same day, and dropped considerably the next day during regular trading hours.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.